ArticleJournal of managed care & specialty pharmacy2024

Dose escalation of biologics in biologic-naive patients with Crohn's disease: Outcomes from the ODESSA-CD study.

Noa Krugliak Cleveland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.